Neuroregenerative effects of preinjury FK-506 administration

Plastic and Reconstructive Surgery

Volumn 118, Issue 2, 2006, Pages 360-367

  Snyder, Alison K ^a   Fox, Ida K ^a   Nichols, Chris M ^a   Rickman, Susan R ^a   Hunter, Daniel A ^a   Tung, Thomas H H ^a   Mackinnon, Susan E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NERVE REGENERATION; NERVE TRANSECTION; NONHUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TIBIAL NERVE;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; NERVE REGENERATION; NEUROSURGICAL PROCEDURES; PERIPHERAL NERVOUS SYSTEM AGENTS; PREOPERATIVE CARE; RATS; RATS, INBRED LEW; TACROLIMUS; TIBIAL NERVE; TRAUMA, NERVOUS SYSTEM;

EID: 33746683259     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000227628.43867.5b     Document Type: Article

References (69)

1. Price, R. D., Yamaji, T., and Matsuoka, N. FK-506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway. Br. J. Pharmacol. 140: 825, 2003.
2. Steiner, J. P., Hamilton, G. S., Ross, D. T., et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A. 94: 2019, 1997.
3. Steiner, J. P., Connolly, M. A., Valentine, H. L., et al. Neurotrophic actions of non-immunosuppressive analogues of immunosuppressive drugs FK-506, rapamycin and cyclosporin A. Nat. Med. 3: 421, 1997.
4. Lyons, W. E., George, E. B., Dawson, T. M., et al. Immunosuppressant FK-506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. U.S.A. 91: 3191, 1994.
5. Yang, R. K., Lowe, J. B., III, Sobol, J. B., et al. Dose-dependent effects of FK-506 on neuroregeneration in a rat model. Plast. Reconstr. Surg. 112: 1832, 2003.
6. Chunasuwankul, R., Ayrout, C., Dereli, Z., et al. Low dose discontinued FK-506 treatment enhances peripheral nerve regeneration. Int. Surg. 87: 274, 2002.
7. Jost, S. C., Doolabh, V. B., and Mackinnon, S. E. Acceleration of peripheral nerve regeneration following FK-506 administration. Restor. Neurol. Neurosci. 17: 39, 2000.
8. Becker, D. B., Jensen, J. N., Myckatyn, T. M., et al. Effects of FKBP-12 ligands following tibial nerve injury in rats. J. Reconstr. Microsurg. 16: 613, 2000.
9. Udina, E., Ceballos, D., Gold, B. G., et al. FK-506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp. Neurol. 183: 220, 2003.
10. Udina, E., Ceballos, D., Verdu, E., et al. Bimodal dose-dependence of FK-506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve 26: 348, 2002.
11. Sezen, S. F., Hoke, A., and Burnett, A. L. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat. Med. 7: 1073, 2001.
12. Lee, M., Doolabh, V. B., Mackinnon, S. E., et al. FK-506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 23: 633, 2000.
13. Gold, B. G., Densmore, V., Shou, W., et al. Immunophilin FK-506-binding protein 52 (not FK-506-binding protein 12) mediates the neurotrophic action of FK-506. J. Pharmacol. Exp. Ther. 289: 1202, 1999.
14. Gold, B. G., Gordon, H., and Wang, M. S. Efficacy of delayed or discontinuous FK-506 administrations on nerve regeneration in the rat sciatic nerve crush model: Lack of evidence for a conditioning lesion-like effect. Neurosci. Lett. 267: 33, 1999.
15. Wang, M. S., Zeleny-Pooley, M., and Gold, B. G. Comparative dose-dependence study of FK-506 and cyclosporine A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 282: 1084, 1997.
16. Gold, B. G., Storm-Dickerson, T., and Austin, D. R. The immunosuppressant FK-506 increase functional recovery nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6: 287, 1994.
17. Gold, B. G., Katoh, K., and Storm-Dickerson, T. The immunosuppressant FK-506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15: 7509, 1995.
18. Myckatyn, T. M., Ellis, R. A., Grand, A. G., et al. The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast. Reconstr. Surg. 109: 2405, 2002.
19. Navarro, X., Udina, E., Ceballos, D., et al. Effects of FK-506 on nerve regeneration and reinnervation after graft or tube repair of long nerve grafts. Muscle Nerve 24: 905, 2001.
20. Doolabh, V. B., and Mackinnon, S. E. FK-506 accelerates functional recovery following nerve grafting in a rat model. Plast. Reconstr. Surg. 103: 1928, 1999.
21. Fansa, H., Keilhoff, G., Altmann, S., et al. The effect of the immunosuppressant FK 506 on peripheral nerve regeneration following nerve grafting. J. Hand Surg. (Br.) 24: 38, 1999.
22. Okajima, S., Hojo, T., Tamai, K., et al. Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressant agent. Microsc. Res. Tech. 58: 52, 2002.
23. Mackinnon, S. E., Doolabh, V. B., and Novak, C. B. Clinical outcome following nerve allograft transplantation. Plast. Reconstr. Surg. 107: 1419, 2001.
24. Feng, F. Y., Ogden, M. A., Myckatyn, T. M., et al. FK-506 rescues peripheral nerve allografts in acute rejection. J. Neurotrauma 18: 217, 2001.
25. Weinzweig, N., Grindel, S., Gonzalez, M., et al. Peripheralnerve allotransplantation in rats immunosuppressed with transient or long-term FK-506. J. Reconstr. Microsurg. 12: 451, 1996.
26. Buttemeyer, R., Rao, U., and Jones, N. F. Peripheral nerve allograft transplantation with FK-506: Functional, histological, and immunological results before and after discontinuation of immunosuppression. Ann. Plast. Surg. 35: 396, 1995.
27. Sulaiman, O. A., Voda, J., Gold, B. G., et al. FK-506 increases peripheral nerve regeneration after chronic axotomy but not after chronic Schwann cell denervation. Exp. Neurol. 175: 127, 2002.
28. Kihara, M., Kamijo, M., Nakasaka, Y., et al. A small dose of the immunosuppressive agent FK-506 (tacrolimus) protects peripheral nerve from ischemic fiber degeneration. Muscle Nerve 24: 1601, 2001.
29. Bain, J. R. Peripheral nerve and neuromuscular allotransplantation: Current status. Microsurgery 20: 384, 2000.
30. Wang, M. S., and Gold, B. G. FK-506 increases the regeneration of spinal cord axons in a pre-degenerated peripheral nerve autograft. J. Spinal Cord Med. 22: 287, 1999.
31. Sharkey, J., and Butcher, S. P. Immunophilins mediate the neuroprotective effects of FK-506 in focal cerebral ischemia. Nature 371: 336, 1994.
32. Ide, T., Morikawa, E., and Kirino, T. An immunosuppressant, FK-506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil. Neurosci. Lett. 204: 157, 1996.
33. Tokime, T., Nozaki, K., and Kikuchi, H. Neuroprotective effect of FK-506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206: 81, 1996.
34. Butcher, S. P., Henshall, D. C., Teramura, Y., et al. Neuroprotective actions of FK-506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17: 6939, 1997.
35. Dawson, T. M., Steiner, J. P., Dawson, V. L., et al. Immunosuppressant FK-506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 90: 9808, 1993.
36. Kikuchi, M., Kashii, S., Mandai, M., et al. Protective effects of FK-506 against glutamate-induced neurotoxicity in retinal cell culture. Invest. Ophthalmol. Vis. Sci. 39: 1227, 1998.
37. Kitamura, Y., Itano, Y., Kubo, T., et al. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57FL/6 mice. J. Neuroimmunol. 50: 221, 1994.
38. Iwasaki, Y., Ichikawa, Y., Igarashi, O., et al. Neuroprotective actions of FK-506 and cyclosporine A on motor neuron survival following neonatal axotomy. Neurol. Res. 24: 573, 2002.
39. Winter, C., Schenkel, J., Burger, E., et al. The immunophilin ligand FK-506, but not GPI-1046, protects against neuronal death and inhibits c-JUN expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. Neuroscience 95: 753, 2000.
40. Grand, A., Myckatyn, T., Mackinnon, S., et al. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J. Neurosurg. 96: 926, 2002.
41. Tanaka, K., Fujita, N., Higashi, Y., et al. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells. Neurosci. Lett. 330: 147, 2002.
42. Klettner, A., Baumgrass, R., Zhang, Y., et al. The neuroprotective actions of FK-506 binding protein ligands: Neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Mol. Brain Res. 97: 21, 2001.
43. Gao, X., Dawson, V. L., and Dawson, T. M. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci. 13: 1683, 2001.
44. Gold, B. G., Zeleny-Pooley, M., Wang, M. S., et al. A non-immunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147: 269, 1997.
45. Sobol, J. B., Lowe, J. B., III, and Yang, R. K. Effects of delaying FK-506 administration on neuroregeneration in a rodent model. J. Reconstr. Microsurg. 19: 113, 2003.
46. Brenner, M. J., Fox, I. K., Kawamura, D. H., et al. Delayed nerve repair is associated with diminished neuroenhancement by FK-506. Laryngoscope 114: 570, 2004.
47. Myckatyn, T., Ellis, R., Grand, A., et al. The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast. Reconstr. Surg. 109: 2405, 2002.
48. Grumbles, R. M., Casella, G. T., Rudinsky, M. J., et al. The immunophilin ligand FK506, but not the P38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons. Neuroscience 130: 619, 2005.
49. Udina, E., Gold, B. G., and Navarro, X. Comparison of continuous and discontinuous FK506 administration on autograft or allograft repair of sciatic nerve resection. Muscle Nerve 29: 812, 2004.
50. Mabuchi, M., Kawamura, I., Takeshita, S., et al. Insulin-like growth factor-I enhances choleretic action of FK506 in rats. Transplant. Proc. 35: 1596, 2003.
51. Grand, A. G., Myckatyn, T. M., and Mackinnon, S. E. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J. Neurosurg. 96: 924, 2002.
52. Akita, K., Ogawa, M., and Mandel, T. E. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. Cell Transplant. 3: 61, 1994.
53. Murase, N., Starzl, T. E., Demetris, A. J., et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 55: 701, 1993.
54. Kobayashi, J., Mackinnon, S. E., Watanabe, O., et al. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve 20: 858, 1997.
55. Klettner, A., and Herdegen, T. The immunophilin-ligands FK-506 and V-10367 mediate neuroprotection by the heat shock response. Br. J. Pharmacol. 138: 1004, 2003.
56. Herdegen, T., Fischer, G., and Gold, B. G. Immunophilin ligands as a novel treatment for neurological disorders. Trends Pharmacol. Sci. 21: 3, 2000.
57. Gold, B. G., Zeleny-Pooley, M., Chaturvedi, P., et al. Oral administration of a non-immunosuppressant FKBP-12 ligand speeds nerve regeneration. Neuroreport 9: 553, 1998.
58. Owens-Grillo, J. K., Hoffmann, K., Hutchison, K. A., et al. The cyclosporin A-binding immunophilin CyP-40 and the FK-506-binding immunophilin hsp56 bind to a common site on hsp90 and exit in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270: 20479, 1995.
59. Perrot-Applanat, M., Cibert, C., Geraud, G., et al. The 59 kDa FK-506-binding protein, a 90 kDa heat shock protein immunophilin (FKBP59-HBI), is associated with the nucleus, the cytoskeleton and mitotic apparatus. J. Cell Sci. 108: 2037, 1995.
60. Czar, M. J., Owens-Grillo, J. K., Yem, A. W., et al. The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol. Endocrinol. 8: 1731, 1994.
61. Kralli, A., and Yamamoto, K. R. An FK-506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271: 17152, 1996.
62. Yamamoto, C., and Narita, N. The clinical usefulness of the combined use of inhaled beta 2-agonist and inhaled steroid in asthma (in Japanese). Nippon Rinsho 54: 3087, 1996.
63. Madsen, J. R., MacDonald, P., Irwin, N., et al. Tacrolimus (FK-506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154: 673, 1998.
64. Gold, B. G., Yew, J., and Zeleny-Pooley, M. The immunosuppressant FK-506 increases GAP-43 mRNA levels in axotomized sensory neurons. Neurosci. Lett. 241: 25, 1998.
65. Jones, K. J., Drengler, S. M., and Oblinger, M. M. Gonadal steroid regulation of growth-associated protein GAP-43 mRNA expression in axotomized hamster facial motor neurons. Neurochem. Res. 22: 1367, 1997.
66. Yao, G. L., and Kiyama, H. Dexamethasone enhances level of GAP-43 mRNA after nerve injury and facilitates re-projection of the hypoglossal nerve. Mol. Brain Res. 32: 308, 1995.
67. Costigan, M., Manion, R. J., Kendall, G., et al. Heat shock protein 27: Developmental regulation and expression after peripheral nerve injury. J. Neurosci. 18: 5891, 1998.
68. Hirata, K., He, J., Hirakawa, Y., et al. HSP27 is markedly induced in Schwann cell columns and associated regenerating axons. Glia 42: 1, 2003.
69. Steiner, J. P., Dawson, T. M., Fotuhi, C., et al. The immunosuppressant FK-506 enhances phosphorylation of GAP43: Implications for a role in modulation of growth cone function and neurotransmitter release. Soc. Neurosci. Abstr. 18: 603, 1991.